New research from CU Anschutz scientists suggests that staying physically active after heart rhythm treatment may ...

Last week, the leading developers of treatments for atrial fibrillation (AFib) convened in Boston for the 2026 AF Symposium.

Argá Medtech today announced positive findings from a first-in-human study of its Coherent Sine-Burst Electroporation (CSE) system.

New research from CU Anschutz scientists suggests that staying physically active after heart rhythm treatment may ...

Johnson & Johnson, Boston Scientific and Abbott were among the companies showcasing new data on atrial fibrillation ...

Abbott on Friday presented one-year clinical trial results for the Volt pulsed field ablation system alongside six-month CE ...

Coherent Sine-Burst Electroporation™ Platform demonstrates 100% procedural success and high freedom from AF in paroxysmal and persistent patients COHERENT-AF U.S. Investigational Device Exemption (IDE ...

Pulse Biosciences PLSE recently announced late-breaking data from its first-in-human feasibility study of the nPulse Cardiac ...

A catheter ablation procedure widely used to treat the most common heart rhythm disorder significantly reduces the burden of atrial fibrillation (AF) and results in clinically important improvements ...

"The Healthy Geezer" answers questions about health and aging in his weekly column. Question: When doctors perform a cardiac ablation, what exactly do they do? Answer: Ablation is a surgical excision ...